Julie Grabow, an oncologist at the Fred Hutchinson Cancer Center in Seattle, recently prescribed an exciting new therapy for a 60-year-old woman with metastatic breast cancer — Afinitor made by Novartis. There was a catch, though. Novartis is charging $10,000 per month for the drug
With reference pricing, to charge Medicare extra companies get three years to show that a new, costly treatment is better than the old one.
FDA shouldn’t cave to pressure and allow Genentech to keep advanced metastatic breast cancer on the Avastin label, argues Merrill Goozner.
Clinical trials that compare effectiveness–and safety–of new drugs with old drugs would not only save lives, but money as well, says Merrill Goozner
LocalHealthGuide is a health news and information web service for Seattle and the Puget Sound Region. We are independent and unaffiliated with any hospital, medical association or insurer. If you have questions or if your group has an upcoming event that you would like us to cover, please let us know by going to our "Contact Us" page and dropping us a note. -- Michael McCarthy, Editor
Enter your email address below to receive updates each time we publish new content.
Seattle Times Health News
Experts divided over recommendation to screen children for cholesterol
Some clinicians say universal screening is an important tool to help identify children who are genetically predisposed to high cholesterol and to pinpoint others who could benefit from treatment. Others express concerns that screening may do more harm than good.
People in state high-risk insurance plans often feel left behind
The federal health law set up new plans that are cheaper and more comprehensive than the older ones run by states but consumers need to go without insurance for six months to qualify.
Peeking in on your doctor’s notes
Although federal law guarantees patients the right to examine and get copies of their medical records, providers haven’t always made it easy to do so. But the movement to give patients direct access to their health information has picked up steam, and policymakers have encouraged it as a way to empower patients to help manage their health and their medical care.
Add to Google
Recent Comments